Metoprolol Succinate is a cardioselective beta-blocker used in the management of hypertension and related cardiovascular conditions. This prolonged-release formulation is designed for sustained drug release, supporting extended dosing intervals.

Each unit of this beta-blocker antihypertensive tablet contains Metoprolol Succinate IP 47.5 mg (equivalent to Metoprolol Tartrate 50 mg, prolonged release), formulated in tablets form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating cardiovascular management medication for their regional markets.

Indicated for use in the management of hypertension and other cardiovascular conditions as directed by a physician. Suitable for supply to hospitals, cardiology clinics, and pharmaceutical distributors.

Packed in 10x10 blister strips designed to protect tablet integrity during international freight and storage. The 10x10 Tablets configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing prolonged release metoprolol formulation in bulk quantities.

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying beta-blocker antihypertensive tablet to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Metoprolol Succinate Prolonged Release Tablets IP Cdmet-Xr-50?
A: It contains Metoprolol Succinate IP 47.5 mg (equivalent to Metoprolol Tartrate 50 mg, prolonged release), manufactured to Indian Pharmacopoeia (IP) standards in tablets form.

Q: What pack sizes are available for Metoprolol Succinate Prolonged Release Tablets IP Cdmet-Xr-50?
A: This product is supplied in 10x10 Tablets export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Metoprolol Succinate Prolonged Release Tablets IP Cdmet-Xr-50?
A: Metoprolol Succinate Prolonged Release Tablets IP Cdmet-Xr-50 is manufactured and supplied by CD&M Remedies, under product code 1003.

Q: Which product category does Metoprolol Succinate Prolonged Release Tablets IP Cdmet-Xr-50 belong to?
A: It falls under the Cardiovascular Medication (Beta-Blocker / Antihypertensive) category, intended for B2B pharmaceutical buyers and importers.